GlassScriptPhysician profile
Christina Chen
NPI 1225196090
$3,497.46
in general payments reported to CMS, 2019-2025
37 companies · $567 in 2025
The $567 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $53.80 · 2021: $219 · 2022: $717 · 2023: $974 · 2024: $683 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,224.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $695.11 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $679.31 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $324.41 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $289.24 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $219.96 | 2019-2025 | Veozah, Myrbetriq, Vesicare |
| Pfizer INC. | $146.98 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.23 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $118.19 | 2022-2025 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $80.24 | 2019-2024 | Injectafer |
| Amgen INC. | $71.28 | 2019-2025 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.70 | 2019-2022 | |
| Exact Sciences Corporation | $52.32 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $48.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $47.07 | 2022-2023 | |
| Glaxosmithkline, LLC. | $44.86 | 2019-2023 | Shingrix, Arexvy |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.